高级检索

肝脾联合切除和胃左血管离断术治疗肝癌合并门脉高压症的临床意义

易永祥, 韩建波, 刘涛

易永祥, 韩建波, 刘涛. 肝脾联合切除和胃左血管离断术治疗肝癌合并门脉高压症的临床意义[J]. 实用临床医药杂志, 2011, (19): 52-54. DOI: 10.3969/j.issn.1672-2353.2011.19.016
引用本文: 易永祥, 韩建波, 刘涛. 肝脾联合切除和胃左血管离断术治疗肝癌合并门脉高压症的临床意义[J]. 实用临床医药杂志, 2011, (19): 52-54. DOI: 10.3969/j.issn.1672-2353.2011.19.016
shu
YI Yong-xiang, HAN Jian-bo, LIU Tao. Role of united hepatectomy and splenctomy and ligation of the left gastric vein in the surgical treatment of hepatocellular carcinoma complicated with portal hypertension[J]. Journal of Clinical Medicine in Practice, 2011, (19): 52-54. DOI: 10.3969/j.issn.1672-2353.2011.19.016
Citation: YI Yong-xiang, HAN Jian-bo, LIU Tao. Role of united hepatectomy and splenctomy and ligation of the left gastric vein in the surgical treatment of hepatocellular carcinoma complicated with portal hypertension[J]. Journal of Clinical Medicine in Practice, 2011, (19): 52-54. DOI: 10.3969/j.issn.1672-2353.2011.19.016
shu

肝脾联合切除和胃左血管离断术治疗肝癌合并门脉高压症的临床意义

  • 东南大学附属第二医院外科,江苏南京,210003

详细信息

  • 中图分类号: R730.56

Role of united hepatectomy and splenctomy and ligation of the left gastric vein in the surgical treatment of hepatocellular carcinoma complicated with portal hypertension

摘要

    摘要
  • 摘要: 目的:探讨原发性肝癌合并门脉高压患者行肝脾联合切除、胃左血管离断的临床意义.方法 回顾分析26例原发性肝癌合并门脉高压症患者,行肝脾联合切除、胃左血管离断术14例(联合切除组),行单纯肝癌切除组12例(单独切除组),比较两组的术后并发症、血常规变化,术后两年肿瘤的复发率、死亡率及上消化道出血率.结果 术前两组之间基本资料及术后并发症无统计学意义,联合切除组两年肿瘤复发率及上消化道出血率明显低于单独切除组,两组肿瘤复发率分别为14.3％和58.3％,上消化道出血率分别为7.14％和41.7％,且两者之间差异有统计学意义,各组的两年死亡率分别为14.3％和41.7％,两者之间无统计学差异.结论 肝癌切除联合脾脏切除、胃左血管离断术,该手术是安全的,可有效降低上消化道出血的发生率和肿瘤复发率.
    • HTML全文
    • 参考文献(11)
  • Sugimachi K, Ikeda Y, Tomikawa M. Appraisal of hepatic resection in the treatment of hepatocellular carcinoma with severe thrombocytopenia [J]. World Journal of Surgery, 2008(6):1077.doi: 10.1007/s00268-007-9442-3.
    Bi X Y, Zhao J J, Yan T. Peri-operative treatment for hepatocellular carcinoma patients complied with cirrhosis and hypersplenism [J]. Zhonghua WaiKe ZaZhi, 2010, (20):1539.doi: 10.3760/cma.j.issn.0529-5815.2010.20.006.
    Ohno T, Furui J, Hashimoto T. Simultaneous laparoscopic hand-assisted hepatectomy and splenectomy for liver cancer with hypersplenism:Report of a case [J]. Surgery today (The Japanese Journal of Surgery), 2011(3):444.
    Arakawa Y, Shimada M, Uchiyama H. Beneficial effects of splenectomy on massive hepatectomy model in rats [J]. Hepatology Research, 2009(4):391.
    Wang Q, Sun K, Li X H. Surgical treatment for hepatocellular carcinoma and secondary hypersplenism [J]. Hepatobiliary & Pancreatic Diseases International, 2006(3):396.
    Chen X P, Wu Z D, Qiu F Z. Role of united hepatectomy and splenectomy in the surgical treatment of hepatocellular carcinoma complicated with hepatic cirrhosis and hypersplenism [J]. Zhonghua Waike Zazhi, 2005(7):442.doi: 10.3760/j:issn:0529-5815.2005.07.011.
    Morinaga A, Ogata T, Kage M. Comparison of liver regeneration after a splenectomy and splenic artery ligation in a dimethylnitrosamine-induced cirrhotic rat model [J]. HPB (Oxford), 2010(1):22.
    Eipel C, Abshagen K, Ritter J. Splenectomy improves survival by increasing arterial blood supply in a rat model of reduced-size liver [J]. Transplant International, 2010, (10):998.doi: 10.1111/j.1432-2277.2010.01079.x.
    Nanashima A, Sumida Y, Abo T, Shibata K. Treatment of concomitant gastric variees in patients with hepatocellular carcinoma at a single Japaneae institute [J]. Hepato-Gastroenterology, 2009, (91-92):857.
    Sugo H, Fujiwara N, Yoshimoto J. Additional Hassab's operation for esophagogastric varices in cirrhotic patients with resectable hepatocellular carcinoma [J]. Hepato-Gastroenterology, 2008, (86-87):1686.
    Lacerda C M, Freire W, Vieira de Melo PS. Splenectomy and ligation of the left gastric vein in schistosomiasis mansoni:the effect on esophageal variceal pressure measured by a non-invasive technique [J]. Keio Journal of Medicine, 2002(2):89.
    • 相关文章
    • 施引文献(9)

  • 期刊类型引用(8)

    1. 蔡蕊，商婷婷，周琳，王翠平，袁伟. 血清α-HBDH和ApoB水平对合并MVD的AMI患者PCI术后3年内MACE发生的预测价值. 江苏医药. 2024(04): 334-337 . 百度学术
    2. 陈文荣，黄焯文，欧阳卓兴. 心力衰竭合并心室重构患者血清胱抑素C、N-末端脑钠肽前体、心肌酶谱的临床诊断价值. 中国医药科学. 2024(23): 185-188+198 . 百度学术
    3. 李晨. 磷酸肌酸钠联合新活素对心肌梗死PCI术后心力衰竭患者心肌损伤标志水平和预后的影响. 罕少疾病杂志. 2022(03): 48-50 . 百度学术
    4. 连延华，高丽，张晓乐. 增强型体外反搏抑制老年稳定性冠心病患者心脏重塑的效果及其对缺血阈及血管内皮功能的影响机制分析. 中国医学工程. 2022(08): 125-128 . 百度学术
    5. 阙嘉，钟敏，张又红. 心肌声学造影结合心肌酶、动态心电图早期评估左室心肌情况应用. 现代医用影像学. 2021(05): 972-973+987 . 百度学术
    6. 高怀燕，佟瑶，冯秋婷. 心脏康复策略对冠心病患者心肌酶谱及心室重塑的影响. 国际医药卫生导报. 2021(05): 647-649 . 百度学术
    7. 孙婧，李萍. 冠心病患者的系统性心肺康复护理. 实用临床医药杂志. 2020(14): 122-125 . 本站查看
    8. 王蕾，柯剑林，赵可辉，赵传珂. 2D-STE在评价急性心肌梗死后存活心肌及左室整体收缩功能中的价值. 医学影像学杂志. 2020(12): 2198-2202 . 百度学术

    其他类型引用(1)

    • 资源附件(0)
计量
  • 文章访问数:  133
  • HTML全文浏览量:  24
  • PDF下载量:  8
  • 被引次数: 9
出版历程
  • 发布日期:  2012-03-18

目录

摘要
HTML全文
    参考文献(11)
    相关文章
    施引文献
    资源附件(0)

    /

    返回文章
    返回

    © 2020 《实用临床医药杂志》编辑部

    地址：江苏省扬州市江阳中路136号，扬州大学江阳路北校区14号楼201室邮编：225009电话：0514-87978917、87978989、87978807

    苏公网安备 32100302010246号

    本系统由 北京仁和汇智信息技术有限公司 开发  百度统计

    x 关闭 永久关闭